Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Michael Mahoney; Chairman of the Board, President, Chief Executive Officer; Boston Scientific Corp Daniel Brennan; Chief Financial Officer, Executive Vice President; Boston Scientific Corp Kenneth ...

Michael Mahoney; Chairman of the Board, President, Chief Executive Officer; Boston Scientific Corp Daniel Brennan; Chief Financial Officer, Executive Vice President; Boston Scientific Corp Kenneth ...

Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Truist Financial analyst Richard Newitter maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of $120.00. The company’s shares closed yesterday at ...

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that develops, manufactures, and markets a broad range of innovative products.

Apollo Global Management is seeking to build a marketplace that would allow investors to buy and sell high-grade private assets more easily, while encroaching further into terrain once dominated ...

Apollo Global Management has built a $5 billion multistrategy credit fund with a 30-year maturity as private capital firms increasingly look for novel ways to attract insurance-industry cash.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But that could be changing soon. Martha Sheridan, head of the Meet Boston tourism bureau, just returned from a trade mission to Hyderabad, organized by the Brand USA marketing partnership ...